Patent · US Active

Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

US10548904B2 · kind B2 · utility

1Cited by

53References

12Claims

0Family size

Assignee

Ferring B.V. · NL

Inventors

Salah U. Ahmed · New City, US
Jiaxiang Tsao · Nanuet, US
Anu Mahashabde · Kendall Park, US
Diane D. Harrison · Villanova, US

Key dates

Filing date	Oct 3, 2013
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Oct 3, 2033

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB29L2031/753
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.